pCPR

Project "pCPR" data sheet

The following table provides information about the project.

 Partnership

Take a look of project's partnership.

Map

 Project objective

Sudden cardiac arrest affects up to 1 million people in US and Europe per year, being the 3rd leading cause of death globally. Despite international medical efforts, 9 out of 10 people will die after a cardiac arrest (average survival rate 10.6%). In the European Union, cardiovascular disease costs to the economy more than €192 billion annually. Emergency teams suffer the most with the extremely high mortality and morbidity rates due to cardiac arrest worldwide. Currently, medical assistive devices play a limited role on teams’ diagnostics and therapeutic actions during rescue emergencies. Nevertheless, the defibrillation/CPR devices global market was valued at $1.7B in 2014 and is expected to grow until 2019 with a CAGR of 8% reflecting a strong market demand. pCPR is a portable, precise and personalized medical device to properly assist emergency teams during sudden cardiac arrest emergencies. It consists of a thoracic pad with sensors that doctors, nurses and paramedics apply directly to the patient linked to a new monitor display and defibrillator to support and guide their critical decision-making and patient-specific emergent therapy. The value proposition of pCPR is based on emergency end-users’ feedback and experts’ calls for action, through a lean fast-to-market strategy, delivering unique selling points: - Adaptive physiological feedback (disruptive innovation); - Focus on cerebral oxygen saturation, temperature and tcCO2 (new target indicators); - Clinical reasoning algorithms (cognitive aids at point of care); - Cardiac/Neurologic outcomes guidance (assisting device); - Data management for Quality control (analytics); - Exclusively non-invasive sensors (technology); pCPR wants to be one of the leading assistive device for emergency teams worldwide in a 5-years’ time frame, building upon its patented thoracic pad and combined sensing capabilities to deliver better cost-effective patient care and health outcomes, namely the cardiac arrest survival rate.